Seres Therapeutics announces David Arkowitz to join as EVP CFO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seres Therapeutics announces presentation of Phase 3 Ecospor III study data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mersana Therapeutics announces resignation of CFO David Spellman
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seres Therapeutics announces three-year research collaboration with AstraZeneca
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rain Therapeutics announces anticipated milestones
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Autolus Therapeutics announces an additional publication for AUTO1
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hoth Therapeutics announces virtual exhibits on HT-KIT, HT-001
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MindMed announces launch of collaboration with Nextage Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
PSE&G President David Daly announces retirement, Kim Hanemann to succeed
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Protagonist Therapeutics announces first subject dose in phase 1 study of PN-232
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Larimar Therapeutics announces $95M private placement of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento Therapeutics announces first patient treated in Enbrel study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ADC Therapeutics announces three abstracts to be presented at ASCO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Allogene Therapeutics announces results from ALLO-501, ALLO-501A studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Prime Therapeutics announces August return-to-work date
It will raise its capacity at the Eagan office building, known internally as Prime Landing, up to about 25% starting August 2......»»
Silence Therapeutics announces data from GEMINI Phase 1 study of SLN124
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioXcel Therapeutics announces FDA acceptance of NDA filing for BXCL501
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Summit Therapeutics announces preclinical candidate SMT026738
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seres Therapeutics assumed with a Neutral at Goldman Sachs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Earnings Outlook for Onconova Therapeutics
Onconova Therapeutics (NASDAQ:ONTX) announces its next round of earnings this Monday, May 17. Here is Benzinga's everything-that-matters guide for this Monday's .....»»
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
SEATTLE, May 14, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a cl.....»»